Search

Significance: Hyperspectral imaging (HSI) can support intraoperative perfusion assessment, the identification of tissue structures, and the detection of cancerous lesions. The practical use of HSI for minimal-invasive surgery is currently limited, for example, due to long acquisition times, missing video, or large set-ups. Aim: An HSI laparoscope is described and evaluated to address the requirements for clinical use and high-resolution spectral imaging. Approach: Reflectance measurements with reference objects and resected human tissue from 500 to 1000 nm are performed to show the consistency with an approved medical HSI device for open surgery. Varying object distances are investigated, and the signal-to-noise ratio (SNR) is determined for different light sources. Results: The handheld design enables real-time processing and visualization of HSI data during acquisition within 4.6 s. A color video is provided simultaneously and can be augmented with spectral information from push-broom imaging. The reflectance data from the HSI system for open surgery at 50 cm and the HSI laparoscope are consistent for object distances up to 10 cm. A standard rigid laparoscope in combination with a customized LED light source resulted in a mean SNR of 30 to 43 dB (500 to 950 nm). Conclusions: Compact and rapid HSI with a high spatial- and spectral-resolution is feasible in clinical practice. Our work may support future studies on minimally invasive HSI to reduce intra- and postoperative complications.

Free tissue transfer (FTT) surgery for breast reconstruction following mastectomy has become a routine operation with high success rates. Although failure is low, it can have a devastating impact on patient recovery, prognosis, and psychological well-being. Continuous and objective monitoring of tissue oxygen saturation (StO2) has been shown to reduce failure rates through rapid detection time of postoperative vascular complications. We have developed a pervasive wearable wireless device that employs near-infrared spectroscopy (NIRS) to continuously monitor FTT via StO2 measurement. Previously tested on different models, the results of a clinical study are introduced. Our goal for the study is to demonstrate that the developed device can reliably detect StO2 variations in a clinical setting: 14 patients were recruited. Advanced data analysis was performed on the StO2 variations, the relative StO2 gradient change, and the classification of the StO2 within different clusters of blood occlusion level (from 0% to 100% at 25% step) based on previous studies made on a vascular phantom and animals. The outcomes of the clinical study concur with previous experimental results and the expected biological responses. This suggests that the device is able to correctly detect perfusion changes and provide real-time assessment on the viability of the FTT in a clinical setting.